Skip to search.
 FTSE 100 Down 0.98%

More On AZN

Quotes

Derivatives

  • Warrants
  • Investment Products

Charts

News & Info

Company

  • Profile
  • Key Statistics
  • SEC Filings
  • Competitors
  • Industry
  • Components

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

AstraZeneca PLC (AZN)

-NYSE
28.43 Down 0.26(0.91%) 15:55 - NYSE Real Time Price
Prev Close:28.69
Open:28.32
Bid:28.42 x 1300
Ask:28.43 x 300
1y Target Est:35.91
Beta:0.71793
Next Earnings Date:N/A
Day's Range:28.30 - 28.67
52wk Range:28.29 - 36.69
Volume:2,582,042
Avg Vol (3m):4,248,370
Market Cap:71.87b
P/E (ttm):25.50
EPS (ttm):1.12
Div & Yield:0.90 (3.00%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
AZNDown 0.91%71.87b
GSKDown 0.66%94.89b
PFEDown 0.28%175.82b
MRKDown 0.39%135.88b

Key Statistics

Forward P/E (1 yr):10.27
P/S (ttm):2.94
Ex-Dividend Date:12-Aug-15

Analysts

Annual EPS Est (Dec-16) :2.08
Quarterly EPS Est (Mar-16) :1.15
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):-13.79

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

AstraZeneca PLC engages in the discovery, development, and commercialization of prescription medicines for the treatment of cardiovascular, metabolic, respiratory, inflammation, autoimmune, oncology, infection, and neuroscience diseases worldwide. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback